BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 4341216)

  • 1. [Pharmacoarteriography of the pancreas using secretin, trypsin and histamine].
    Schmarsow R
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:51. PubMed ID: 4341216
    [No Abstract]   [Full Text] [Related]  

  • 2. [The secretin-pancreozymin test in the diagnosis of exocrine pancreatic function (author's transl)].
    Pointner H
    Wien Klin Wochenschr; 1973 Oct; 85(40):665-7. PubMed ID: 4747003
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiography of the pancreas following the administration of secretrin, trypsin and histamine.
    Schmarsow R
    Acta Radiol Diagn (Stockh); 1972 Mar; 12(2):175-83. PubMed ID: 5056025
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis of pancreatic carcinoma].
    Löffler A; Stadelmann O; Miederer SE; Sobbe A
    Dtsch Med Wochenschr; 1974 Oct; 99(40):1976, 81-3. PubMed ID: 4605619
    [No Abstract]   [Full Text] [Related]  

  • 5. The secretin test. Its shortcomings as a practical clinical diagnostic procedure.
    Crozier RE
    Lahey Clin Found Bull; 1970; 19(1):17-21. PubMed ID: 5416055
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of secretin stimulation upon serum immunoreactive trypsin in patients with carcinoma of the pancreas.
    Vezzadini P; Sternini C; Gullo L; Bonora G; Campione O; Marrano D; Labò G
    Surg Gynecol Obstet; 1984 Apr; 158(4):319-21. PubMed ID: 6710292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CEA concentration and cytology in duodenal fluid collected during the Secretin-Pancreozymin test. Attempt at an early diagnosis of pancreatic carcinoma by means of simple procedure.
    Farini R; Nitti D; Del Favero G; Rossi CR; Costantin G; Rebuffi A; Farini A; Piccoli A; Matarazzo R; Lise M; Naccarato R
    Hepatogastroenterology; 1980 Jun; 27(3):213-6. PubMed ID: 7461595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical correlations with pancreatic function tests.
    Hershfield NB; Lind JF; Hildes JA
    Can Med Assoc J; 1968 Jan; 98(4):185-8. PubMed ID: 5638282
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical importance of the secretin-pancreozymin test in the diagnosis of chronic and neoplastic exocrine pancreatopathies].
    Taschieri AM; Pucci C; Scortecci V; Trivellini G
    Arch Ital Chir; 1967; 93(1):697-713. PubMed ID: 5621876
    [No Abstract]   [Full Text] [Related]  

  • 10. [The secretin-pancreozymin test in the diagnosis of pancreatic insufficiency].
    Rick W
    Internist (Berl); 1970 Mar; 11(3):110-7. PubMed ID: 4928886
    [No Abstract]   [Full Text] [Related]  

  • 11. [The assessment of chronic pancreatitis by magnetic resonance and MR cholangiopancreatography. II. The semeiotics and results].
    Pavone P; Laghi A; Catalano C; Panebianco V; Luccichenti G; Fraioli F; Passariello R
    Radiol Med; 1999 Nov; 98(5):373-8. PubMed ID: 10780218
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of secretin test in the diagnosis of pancreatic diseases].
    Descos L; Vagne M
    Lyon Med; 1970 Mar; 223(13):727-33. PubMed ID: 5446471
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secretin test and its applications].
    Lu XH; Chen MZ; Bi ZH; Lu GJ; Fan J; Wen SH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1984 Oct; 6(5):372-4. PubMed ID: 6241092
    [No Abstract]   [Full Text] [Related]  

  • 14. An appraisal of 75 Se-selenomethionine scanning as a test of pancreatic function: a comparison with the secretin-pancreozymin test.
    Braganza J; Critchley M; Howat HT; Testa HJ; Torrance HB
    Gut; 1972 Oct; 13(10):844. PubMed ID: 5087092
    [No Abstract]   [Full Text] [Related]  

  • 15. The two stage provocative test for pancreatic disease by serum enzyme measurements.
    Kim DK; Schwartz MK; Sherlock P
    Surg Gynecol Obstet; 1980 Jan; 150(1):49-53. PubMed ID: 7350701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of intra-arterial secretin and celiac angiography (arteriography coupled with duodenal intubation)].
    Plessier J; Doyon D; Benett J; Stoopen M; Economopoulos P; Chérigié E; Caroli J
    Arch Fr Mal App Dig; 1968; 57(3):307-15. PubMed ID: 5740671
    [No Abstract]   [Full Text] [Related]  

  • 17. [Early detection of pancreatic diseases. Practical consequences].
    Domschke W; Domschke S; Lux G
    Fortschr Med; 1983 Jul; 101(26):1219-23. PubMed ID: 6884958
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical-functional diagnosis of pancreas carcinoma. With special consideration of the pancreozymin-secretin test and proteolytic stool enzyme activity].
    Filippini L; Ammann R
    Schweiz Med Wochenschr; 1967 Jun; 97(25):803-10. PubMed ID: 5592579
    [No Abstract]   [Full Text] [Related]  

  • 19. [Exfoliative pancreas cytology. Cytological examination of duodenal aspirates after secretin stimulation of the pancreas].
    Asnaes S; Johansen AA; Moller N
    Nord Med; 1968; 80(30):979-81. PubMed ID: 4879473
    [No Abstract]   [Full Text] [Related]  

  • 20. The pancreatographic effect during pharmacoangiography of the pancreas.
    Schmarsow R; Peters PE
    Acta Radiol Diagn (Stockh); 1975 Jan; 16(1):73-80. PubMed ID: 1155214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.